QuadraMed Launches ICD-10 Countdown Program at AHIMA 2009

New ICD-10 Coding Simulator Training Solution Receiving High Level of Pre-Show
Interest
RESTON, Va.--(Business Wire)--
QuadraMed® Corporation (NASDAQ:QDHC), a leading provider of healthcare
information technologies and services that help turn quality care into positive
financial outcomes, today announced the launch of its ICD-10 Countdown Program.
This new program includes the Quantim® ICD-10 Coding Simulator software, ICD-10
educational tools and services to guide healthcare providers through the ICD-10
conversion.

The Quantim ICD-10 Coding Simulator will be available for hands-on
demonstrations at the 81st AHIMA Convention & Exhibit taking place October 3-8,
2009 in Grapevine, Texas. Pre-conference interest in the new product has been
high, with almost 100 requests for product demonstrations of the coding
simulator. AHIMA`s e-HIM® Virtual Laboratory, funded by the organization`s
research and education Foundation, is using QuadraMed`s ICD-10 Coding Simulator
throughout the year to train coding students, reaching approximately 170 schools
and over 4,000 students nationwide. QuadraMed was the first in the industry to
deploy an ICD-10 Coding Simulator for coder training in the e-HIM Virtual Lab.

According to the Deloitte Center for Health Solutions, ICD-10 implementation has
the potential to surpass Y2K in both total impact and cost as it drives the
evolution of the global healthcare system. "AHIMA`s adoption of our ICD-10
Countdown Program delivers a strong message to health information management
(HIM) professionals that it`s critical to begin now to ensure a successful
ICD-10 transition - a transition that will impact almost all clinical, financial
and HIM systems in use today," said Duncan W. James, president and CEO of
QuadraMed. "Our ICD-10 Countdown Program provides coders with the hands-on
training and educational services required to gain familiarity with the new
ICD-10 coding methodology."

QuadraMed`s ICD-10 Countdown Program provides clients access to software,
training and educational tools to assist with the transition from ICD-9 to
ICD-10 code sets. QuadraMed`s ICD-10 Countdown Program includes:

* Quantim®ICD-10 Coding Simulator with an introductory 90-day subscription
* ICD-10 fundamentals educational tool
* Online application tutorial, "Countdown to ICD-10"
* Participation in QuadraMed`s ICD-10 community bulletin board

The U.S. healthcare industry has used ICD-9 Clinical Modification (ICD-9-CM)
code sets to encode diagnoses and procedures since the late 1970s. Per the
Senate Bill 628, the United States will finally adopt the ICD-10 system, which
has already been implemented worldwide with the exception of the United States.
U.S. healthcare organizations must now convert from ICD-9 to ICD-10 by the
compliance date of October 1, 2013 or risk losing claims reimbursement from The
Centers for Medicare & Medicaid Services (CMS).

The challenge of the ICD-10 transition lies within its complexity and dramatic
increase in the number of code sets. For example, the number of disease
classifications will rise from 13,000 ICD-9-CM to 68,000 ICD-10-CM codes. For
procedure classifications, the number of codes will expand from 3,000 ICD-9-PCS
to 78,000 ICD-10 PCS codes.

"The transition to ICD-10 will allow healthcare organizations to capture greater
documentation detail for coding, resulting in increased accuracy in data
reporting and reimbursement, as well as consistent compliance with regulatory
and quality reporting requirements. As all U.S. hospitals will be required to
make this coding conversion, QuadraMed foresees an increased demand for our
products and services as healthcare organizations look to us to help them assess
their readiness, train staff and implement ICD-10 compliant solutions," added
James.

The ICD-10 Countdown Program will be available to hospitals, medical groups,
consultants and medical coding groups within the United States. For more
information, visit www.quadramed.com/icd-10.

About QuadraMed Corporation

QuadraMed - (NASDAQ:QDHC) is a leading provider of healthcare technologies and
services that help turn quality care into positive financial outcomes. QuadraMed
provides innovative solutions that streamline processes, ensure compliance and
help healthcare professionals deliver quality patient care. Behind the Company's
products and services is a staff of 600 professionals whose experience and
dedication have earned QuadraMed the trust and loyalty of clients at over 2,000
healthcare provider facilities. For more information about QuadraMed, visit
http://www.quadramed.com.

Cautionary Statement on Risks Associated with QuadraMed Forward-Looking
Statements

This press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 that are subject to risks and
uncertainties. The words "believe," "expect," "target," "goal," "project,"
"anticipate," "predict," "intend," "plan," "estimate," "may," "will," "should,"
"could" and similar expressions and their negatives are intended to identify
such statements. Forward-looking statements are not guarantees of future
performance, anticipated trends or growth in businesses, or other
characterizations of future events or circumstances and are to be interpreted
only as of the date on which they are made. QuadraMed undertakes no obligation
to update or revise any forward-looking statement. You should not place undue
reliance on these forward-looking statements. Our actual results could differ
materially from those anticipated in these forward-looking statements for many
reasons, including the risks faced by QuadraMed described in documents filed
with the Securities and Exchange Commission ("SEC") from time to time.
QuadraMed`s SEC filings can be accessed through the Investor Relations section
of our website, www.quadramed.com, or through the SEC`s EDGAR Database at
www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).

QuadraMed is a registered trademark of QuadraMed Corporation. All other
trademarks are the property of their respective holders.

Kate Donlon
Amendola Communications for QuadraMed Corporation
619-876-2654
kdonlon@ACMarketingPR.com
or
Investor Relations
703-742-5393
InvestorRelations@QuadraMed.com

Copyright Business Wire 2009